Evidence map›Paper›PMID 42336972›Full record

ArticleCommunications engineering2026

EdgeVolution: democratizing multi-objective neural architecture search and end-to-end deployment on microcontrollers.

René Groh, Stefan Dendorfer, Mateo Ávila Pava, Fabio Egle, Sebastian Zimmermann, Andreas M Kist

Abstract read
In one paragraph

Article in Communications engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

René GrohDepartment Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bavaria, Germany. rene.groh@fau.de.ORCID http://orcid.org/0000-0002-3405-1311
Stefan DendorferDepartment Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bavaria, Germany.
Mateo Ávila PavaDepartment Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bavaria, Germany.
Fabio EgleDepartment Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bavaria, Germany.ORCID http://orcid.org/0000-0003-2591-3255
Sebastian ZimmermannDepartment Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bavaria, Germany.
Andreas M KistDepartment Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bavaria, Germany.ORCID http://orcid.org/0000-0003-3643-7776

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 01070136
6 · The paper itself

Abstract

Edge AI holds great potential for extending the use of artificial neural networks to resource-constrained edge devices, such as microcontrollers. Despite this potential, optimizing and deploying neural networks on these platforms remains challenging due to a lack of tools for hardware-specific adaptation, leading to reproducibility issues and suboptimal performance. To address these challenges, we present EdgeVolution, an end-to-end hardware-in-the-loop platform that facilitates multi-objective optimization, neural architecture selection, and direct deployment onto target hardware. We demonstrate the versatility of EdgeVolution through four application use cases, showcasing its wide-ranging applicability. By offering a generic and adaptable pipeline, EdgeVolution enables the creation and deployment of neural network models tailored to specific datasets, classification tasks, and hardware constraints, thereby improving accessibility, performance, and reproducibility for AI applications on edge devices.

Identifiers

PMID42336972
PMCPMC13291272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.